Literature DB >> 1780171

Comparison of different chemotherapy strategies against Schistosoma mansoni in Machakos District, Kenya: effects on human infection and morbidity.

A E Butterworth1, R F Sturrock, J H Ouma, G G Mbugua, A J Fulford, H C Kariuki, D Koech.   

Abstract

A comparison was made of the long-term impact of different methods of administration of chemotherapy (oxamniquine, 30 mg/kg in divided doses; or praziquantel, 40 mg/kg) on prevalence and intensity of Schistosoma mansoni infection in four areas in Kangundo Location, Machakos District, Kenya. In Area A, treatment was offered in October 1983 and again in April 1985 to all infected individuals. In Area H, treatment was offered in April 1985 to individuals excreting greater than or equal to 100 eggs per gram (epg) of faeces. In Area S, treatment was offered in April 1985 to all infected school children, within the framework of the primary schools. In the witness area, Area W, treatment was given in April 1985, for ethical reasons, to a small number of individuals excreting greater than or equal to 800 epg. Prevalence and intensities of infection were subsequently monitored at yearly intervals for three complete post-treatment years. In the Area S schools, clinical examination was also carried out at yearly intervals. Treatment of all infected individuals on two occasions (Area A) was the most effective and long-lasting way of reducing prevalence and intensity of infection. In this area, however, some earlier interventions had been carried out and pre-treatment intensities were lower than in the other areas. Treatment only of infected schoolchildren (Area S) also had a marked and prolonged effect, comparable to or better than treatment of individuals with heavy infections (Area H). Treatment of infected schoolchildren also caused a persistent reduction in the prevalence of hepatomegaly, and there was suggestive evidence from intensities of infection in community stool surveys (but not from incidence rates) of an effect on transmission. In all study areas, reinfection was most rapid and most intense among children. These findings are discussed in the light of theoretical considerations and of results from other studies, both on schistosomiasis and on intestinal helminths. We conclude that, in areas of low morbidity such as Kangundo, chemotherapy of schoolchildren only, at intervals of up to 3 years, is a satisfactory way of producing a long-term reduction in both intensity of infection and morbidity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1780171     DOI: 10.1017/s0031182000059850

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  18 in total

Review 1.  The cost effectiveness of mass drug therapy for intestinal helminths.

Authors:  D B Evans; H L Guyatt
Journal:  Pharmacoeconomics       Date:  1995-07       Impact factor: 4.981

2.  Quality control of Kato slide counts for Schistosoma mansoni: a review of 12 years' experience in Kenya.

Authors:  R F Sturrock; J H Ouma; H C Kariuki; F W Thiongo; D K Koech; A E Butterworth
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

3.  The consequences of uncertainty for the prediction of the effects of schistosomiasis control programmes.

Authors:  M S Chan
Journal:  Epidemiol Infect       Date:  1996-12       Impact factor: 2.451

4.  The development of an age structured model for schistosomiasis transmission dynamics and control and its validation for Schistosoma mansoni.

Authors:  M S Chan; H L Guyatt; D A Bundy; M Booth; A J Fulford; G F Medley
Journal:  Epidemiol Infect       Date:  1995-10       Impact factor: 2.451

Review 5.  Schistosomiasis. Infection versus disease and hypersensitivity versus immunity.

Authors:  A W Cheever
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

6.  Impact of a national helminth control programme on infection and morbidity in Ugandan schoolchildren.

Authors:  Narcis B Kabatereine; Simon Brooker; Artemis Koukounari; Francis Kazibwe; Edridah M Tukahebwa; Fiona M Fleming; Yaobi Zhang; Joanne P Webster; J Russell Stothard; Alan Fenwick
Journal:  Bull World Health Organ       Date:  2007-02       Impact factor: 9.408

Review 7.  Anthelmintics. A comparative review of their clinical pharmacology.

Authors:  N de Silva; H Guyatt; D Bundy
Journal:  Drugs       Date:  1997-05       Impact factor: 9.546

Review 8.  A review and meta-analysis of the impact of intestinal worms on child growth and nutrition.

Authors:  Andrew Hall; Gillian Hewitt; Veronica Tuffrey; Nilanthi de Silva
Journal:  Matern Child Nutr       Date:  2008-04       Impact factor: 3.092

9.  Co-infections with Plasmodium falciparum, Schistosoma mansoni and intestinal helminths among schoolchildren in endemic areas of northwestern Tanzania.

Authors:  Humphrey D Mazigo; Rebecca Waihenya; Nicholas Js Lwambo; Ladislaus L Mnyone; Aneth M Mahande; Jeremiah Seni; Maria Zinga; Anthony Kapesa; Eliningaya J Kweka; Stephen E Mshana; Jorg Heukelbach; Gerald M Mkoji
Journal:  Parasit Vectors       Date:  2010-05-19       Impact factor: 3.876

10.  Parasitic worms: knowledge, attitudes, and practices in Western Côte d'Ivoire with implications for integrated control.

Authors:  Cinthia A Acka; Giovanna Raso; Eliézer K N'goran; Andres B Tschannen; Isaac I Bogoch; Essane Séraphin; Marcel Tanner; Brigit Obrist; Jürg Utzinger
Journal:  PLoS Negl Trop Dis       Date:  2010-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.